VIRVIO
Virvio is a pre-clinical biotherapeutic company developing a broadly-neutralizing peptide capable of both pre- and post- exposure containment of influenza. The drug candidate is being developed as a shelf-stable, single-dose, inhaled product suitable for stockpiling and global pandemic preparedness.
VIRVIO
Industry:
Health Care Therapeutics
Founded:
2015-12-01
Address:
Seattle, Washington, United States
Country:
United States
Website Url:
http://www.virvio.com
Total Employee:
1+
Status:
Closed
Email Addresses:
[email protected]
Total Funding:
209 K USD
Technology used in webpage:
Nginx LeaseWeb Baidu Share NameSilo DNS
Similar Organizations
Calimmune
Calimmune is a clinical-stage gene therapy company.
Chimeron Bio
Chimeron Bio develops agents for personalized cancer gene therapy.
D2M Biotherapeutics
D2M Biotherapeutics focuses on the development of novel immunotherapeutics.
Excision BioTherapeutics
Excision is developing CRISPR-based therapies to cure viral infectious diseases and improve the lives of chronically ill patients.
Lannett Company
Lannett develops, manufactures, and distributes generic prescription pharmaceutical products in tablet.
Scout Bio
Scout Bi is a biotechnology company that provides veterinary, animal health, and gene therapy.
Current Employees Featured
Founder
Investors List
National Institutes of Health
National Institutes of Health investment in Grant - Virvio
Official Site Inspections
http://www.virvio.com
- Host name: a904c694c05102f30.awsglobalaccelerator.com
- IP address: 76.223.54.146
- Location: Seattle United States
- Latitude: 47.54
- Longitude: -122.3032
- Metro Code: 819
- Timezone: America/Los_Angeles
- Postal: 98108
